United States · FDA National Drug Code directory
Lenalidomide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-346_f022fe20-76ac-4825-8986-6e1ec95b0b21
- Product NDC
- 59651-346
- Form
- CAPSULE
- Composition / generic term
- Lenalidomide
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230306
- Source listing expiry
- 20261231
Source-listed ingredients
- LENALIDOMIDE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (59651-346-01) · 59651-346-01
- 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK · 59651-346-07
- 21 CAPSULE in 1 BOTTLE (59651-346-21) · 59651-346-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →